Skip to main content

What the FDA labels say about taking them together

Aprepitant and triazolam

Aprepitant's FDA label of July 5, 2024 names triazolam in its drug interactions section; the triazolam label PlainMeds reads does not name aprepitant. The aprepitant label: “Clinical Impact; Increased exposure to midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) may increase the risk of adverse reactions.”

Check it at the source: the aprepitant FDA label on DailyMed (effective July 5, 2024, Merck Sharp & Dohme LLC); the triazolam FDA label on DailyMed (effective July 10, 2026, Mylan Pharmaceuticals Inc.).

What does the aprepitant label say about triazolam?

Aprepitant label, drug interactions

Clinical Impact; Increased exposure to midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) may increase the risk of adverse reactions [see ].

Source: FDA drug label (EMEND), NDA021549 (Msd), as published by Merck Sharp & Dohme LLC, effective July 5, 2024 (SPL set 696f9e80-9cae-403b-de9e-078343ce4713), via openFDA; the full label on DailyMed

What does the triazolam label say about aprepitant?

Triazolam's label (effective July 10, 2026) does not name aprepitant in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Triazolam), NDA017892 (Pfizer), as published by Mylan Pharmaceuticals Inc., effective July 10, 2026 (SPL set 5add318e-11b9-42f8-b052-0d8cebb32fcf), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

5Aprepitant generic labelers
7Triazolam generic labelers
AprepitantTriazolam
Labeled forNausea and vomitingInsomnia
Boxed warningNoYes
Pharmacy cost (NADAC)$46.42 per capsule 40 mg capsule$0.308 per tablet 0.25 mg tablet
Shortage nowA presentation being discontinuedNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?